Orally Inhaled Drug Particle Transport in Computerized Models of Laryngotracheal Stenosis
Adjuvant management for laryngotracheal stenosis (LTS) may involve inhaled corticosteroids, but metered dose inhalers are designed for pulmonary drug delivery. Comprehensive analyses of drug particle deposition efficiency for orally inhaled corticosteroids in the stenosis of LTS subjects are lacking...
Saved in:
| Published in: | Otolaryngology-head and neck surgery Vol. 164; no. 4; p. 829 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
01.04.2021
|
| Subjects: | |
| ISSN: | 1097-6817, 1097-6817 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Adjuvant management for laryngotracheal stenosis (LTS) may involve inhaled corticosteroids, but metered dose inhalers are designed for pulmonary drug delivery. Comprehensive analyses of drug particle deposition efficiency for orally inhaled corticosteroids in the stenosis of LTS subjects are lacking.
Descriptive research.
Academic medical center.
Anatomically realistic 3-dimensional reconstructions of the upper airway were created from computed tomography images of 4 LTS subjects-2 subglottic stenosis and 2 tracheal stenosis subjects. Computational fluid dynamics modeling was used to simulate airflow and drug particle transport in each airway. Three inhalation pressures were simulated, 10 Pa, 25 Pa, and 40 Pa. Drug particle transport was simulated for 100 to 950 nanoparticles and 1 to 50 micron-particles. Particles were released into the airway to mimic varying inhaler conditions with and without a spacer chamber.
Based on smallest to largest cross-sectional area ratio, the laryngotracheal stenotic segment shrunk by 57% and 47%, respectively, for subglottic stenosis models and by 53% for both tracheal stenosis models. Airflow resistance at the stenotic segment was lower in subglottic stenosis models than in tracheal stenosis models: 0.001 to 0.011 Pa.s/mL vs 0.024 to 0.082 Pa.s/mL. Drug depositions for micron-particles and nanoparticles at stenosis were 0.06% to 2.48% and 0.10% to 2.60% for subglottic stenosis and tracheal stenosis models, respectively. Particle sizes with highest stenotic deposition were 6 to 20 µm for subglottic stenosis models and 1 to 10 µm for tracheal stenosis models.
This study suggests that at most, 2.60% of inhaled drug particles deposit at the stenosis. Particle size ranges with highest stenotic deposition may not represent typical sizes emitted by inhalers. |
|---|---|
| AbstractList | Adjuvant management for laryngotracheal stenosis (LTS) may involve inhaled corticosteroids, but metered dose inhalers are designed for pulmonary drug delivery. Comprehensive analyses of drug particle deposition efficiency for orally inhaled corticosteroids in the stenosis of LTS subjects are lacking.
Descriptive research.
Academic medical center.
Anatomically realistic 3-dimensional reconstructions of the upper airway were created from computed tomography images of 4 LTS subjects-2 subglottic stenosis and 2 tracheal stenosis subjects. Computational fluid dynamics modeling was used to simulate airflow and drug particle transport in each airway. Three inhalation pressures were simulated, 10 Pa, 25 Pa, and 40 Pa. Drug particle transport was simulated for 100 to 950 nanoparticles and 1 to 50 micron-particles. Particles were released into the airway to mimic varying inhaler conditions with and without a spacer chamber.
Based on smallest to largest cross-sectional area ratio, the laryngotracheal stenotic segment shrunk by 57% and 47%, respectively, for subglottic stenosis models and by 53% for both tracheal stenosis models. Airflow resistance at the stenotic segment was lower in subglottic stenosis models than in tracheal stenosis models: 0.001 to 0.011 Pa.s/mL vs 0.024 to 0.082 Pa.s/mL. Drug depositions for micron-particles and nanoparticles at stenosis were 0.06% to 2.48% and 0.10% to 2.60% for subglottic stenosis and tracheal stenosis models, respectively. Particle sizes with highest stenotic deposition were 6 to 20 µm for subglottic stenosis models and 1 to 10 µm for tracheal stenosis models.
This study suggests that at most, 2.60% of inhaled drug particles deposit at the stenosis. Particle size ranges with highest stenotic deposition may not represent typical sizes emitted by inhalers. Adjuvant management for laryngotracheal stenosis (LTS) may involve inhaled corticosteroids, but metered dose inhalers are designed for pulmonary drug delivery. Comprehensive analyses of drug particle deposition efficiency for orally inhaled corticosteroids in the stenosis of LTS subjects are lacking.OBJECTIVEAdjuvant management for laryngotracheal stenosis (LTS) may involve inhaled corticosteroids, but metered dose inhalers are designed for pulmonary drug delivery. Comprehensive analyses of drug particle deposition efficiency for orally inhaled corticosteroids in the stenosis of LTS subjects are lacking.Descriptive research.STUDY DESIGNDescriptive research.Academic medical center.SETTINGAcademic medical center.Anatomically realistic 3-dimensional reconstructions of the upper airway were created from computed tomography images of 4 LTS subjects-2 subglottic stenosis and 2 tracheal stenosis subjects. Computational fluid dynamics modeling was used to simulate airflow and drug particle transport in each airway. Three inhalation pressures were simulated, 10 Pa, 25 Pa, and 40 Pa. Drug particle transport was simulated for 100 to 950 nanoparticles and 1 to 50 micron-particles. Particles were released into the airway to mimic varying inhaler conditions with and without a spacer chamber.METHODSAnatomically realistic 3-dimensional reconstructions of the upper airway were created from computed tomography images of 4 LTS subjects-2 subglottic stenosis and 2 tracheal stenosis subjects. Computational fluid dynamics modeling was used to simulate airflow and drug particle transport in each airway. Three inhalation pressures were simulated, 10 Pa, 25 Pa, and 40 Pa. Drug particle transport was simulated for 100 to 950 nanoparticles and 1 to 50 micron-particles. Particles were released into the airway to mimic varying inhaler conditions with and without a spacer chamber.Based on smallest to largest cross-sectional area ratio, the laryngotracheal stenotic segment shrunk by 57% and 47%, respectively, for subglottic stenosis models and by 53% for both tracheal stenosis models. Airflow resistance at the stenotic segment was lower in subglottic stenosis models than in tracheal stenosis models: 0.001 to 0.011 Pa.s/mL vs 0.024 to 0.082 Pa.s/mL. Drug depositions for micron-particles and nanoparticles at stenosis were 0.06% to 2.48% and 0.10% to 2.60% for subglottic stenosis and tracheal stenosis models, respectively. Particle sizes with highest stenotic deposition were 6 to 20 µm for subglottic stenosis models and 1 to 10 µm for tracheal stenosis models.RESULTSBased on smallest to largest cross-sectional area ratio, the laryngotracheal stenotic segment shrunk by 57% and 47%, respectively, for subglottic stenosis models and by 53% for both tracheal stenosis models. Airflow resistance at the stenotic segment was lower in subglottic stenosis models than in tracheal stenosis models: 0.001 to 0.011 Pa.s/mL vs 0.024 to 0.082 Pa.s/mL. Drug depositions for micron-particles and nanoparticles at stenosis were 0.06% to 2.48% and 0.10% to 2.60% for subglottic stenosis and tracheal stenosis models, respectively. Particle sizes with highest stenotic deposition were 6 to 20 µm for subglottic stenosis models and 1 to 10 µm for tracheal stenosis models.This study suggests that at most, 2.60% of inhaled drug particles deposit at the stenosis. Particle size ranges with highest stenotic deposition may not represent typical sizes emitted by inhalers.CONCLUSIONThis study suggests that at most, 2.60% of inhaled drug particles deposit at the stenosis. Particle size ranges with highest stenotic deposition may not represent typical sizes emitted by inhalers. |
| Author | Cohen, Seth Morris Frank-Ito, Dennis Onyeka |
| Author_xml | – sequence: 1 givenname: Dennis Onyeka surname: Frank-Ito fullname: Frank-Ito, Dennis Onyeka organization: Department of Mechanical Engineering and Materials Science, Duke University, Durham, North Carolina, USA – sequence: 2 givenname: Seth Morris surname: Cohen fullname: Cohen, Seth Morris organization: Department of Head and Neck Surgery & Communication Sciences, Duke University Medical Center, Durham, North Carolina, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33045904$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkLtPwzAYxC1URB-wMyGPLIEv8SseUXhVKioSZWCKXMdpgxw72MlQ_noiUSSmu-F3p9PN0cR5ZxC6TOEmTYW4hVRSJmWegWSSC3qCZilIkfA8FZN_formMX4CAOdCnKEpITDmgM7Qxzooaw946fbKmgrfh2GHX1XoG20N3gTlYudDjxuHC992Q29C8z1yL74yNmJf45UKB7fzfVB6b5TFb71xPjbxHJ3WykZzcdQFen982BTPyWr9tCzuVommOZEJN6QSRPOabrVkrIJa1owwygypGc1kTlNNtqABtGYcNNWqGgOkllTlWshsga5_e7vgvwYT-7JtojbWKmf8EMuMMuA0zyQd0asjOmxbU5VdaNpxffl3R_YDY3Zj3w |
| CitedBy_id | crossref_primary_10_3390_pharmaceutics15030903 crossref_primary_10_1007_s42757_022_0151_9 crossref_primary_10_1016_j_jaerosci_2024_106490 crossref_primary_10_1007_s13665_022_00286_6 crossref_primary_10_1007_s40136_025_00527_7 crossref_primary_10_1016_j_clinbiomech_2024_106231 crossref_primary_10_1089_jamp_2023_0023 crossref_primary_10_3390_pharmaceutics15010160 crossref_primary_10_1002_ohn_831 crossref_primary_10_1002_lary_30212 crossref_primary_10_1186_s42490_023_00068_4 crossref_primary_10_1177_27325016221138749 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1177/0194599820959674 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-6817 |
| ExternalDocumentID | 33045904 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDCR NIH HHS grantid: R01 DE028554 |
| GroupedDBID | --- --K -TM .55 .GJ 01A 123 1B1 1CY 1OB 1OC 1~5 29O 354 4.4 4G. 53G 54M 5RE 5VS 7-5 71M 8F7 AABNK AABOD AAEDT AAHQN AAIKJ AAIPD AAJQC AALRI AAMMB AAMNL AANLZ AAQFI AAQQG AAQQT AAQXK AARDL AARIX AAWTL AAXUO AAYCA ABAFQ ABAWP ABCCA ABEIX ABFNM ABFWQ ABJNI ABKRH ABMAC ABNCE ABQWH ABQXT ABVFX ABWVN ACAEH ACDSZ ACDXX ACGFS ACNXM ACOFE ACRPL ACXQS ADBBV ADBTR ADEBD ADMUD ADNMO ADSTG ADUCT ADZZY AEFGJ AEIGN AEKER AENEX AEQLS AERKM AEUHG AEUYR AEWDL AFEET AFFNX AFFPM AFKRG AFOSN AFUIA AFWVQ AGQPQ AGXDD AGYGG AHBTC AIDQK AIDYY AIEWD AIGII AITUG AITYG AJUZI ALMA_UNASSIGNED_HOLDINGS ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN B8M BDDNI BSEHC BYIEH C45 CAG CDWPY CFDXU CGR COF CS3 CUY CVF DC- DCZOG DE. DOPDO DU5 EBS ECM EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU G-Q GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HGLYW HJTMK HVGLF HZ~ IHE J8X K.F M41 MEWTI NPM NQ- O9- OHH OVD OZT P.B Q1R R2- RIG ROL RPZ S01 SAMSI SAUOL SCNPE SDG SDP SEL SEW SFC SJN SSZ SUPJJ TEORI UDS UGJ WH7 WXSBR X7M ZGI ZONMY ZPPRI ZRKOI ZSSAH ZXP ZY1 7X8 LH4 ~HD |
| ID | FETCH-LOGICAL-c4839-6e3d73c6f4bc955d0f9f53545e3f5429841c3b0c00cc560c4cadd733f94a8c792 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 15 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000637858300018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1097-6817 |
| IngestDate | Thu Oct 02 19:13:05 EDT 2025 Mon Jul 21 06:00:23 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | subglottic stenosis tracheal stenosis spacer chamber metered dose inhalers laryngotracheal stenosis computational fluid dynamics airflow particle transport inhaled corticosteroids |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4839-6e3d73c6f4bc955d0f9f53545e3f5429841c3b0c00cc560c4cadd733f94a8c792 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/8294408 |
| PMID | 33045904 |
| PQID | 2450648294 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2450648294 pubmed_primary_33045904 |
| PublicationCentury | 2000 |
| PublicationDate | April 2021 |
| PublicationDateYYYYMMDD | 2021-04-01 |
| PublicationDate_xml | – month: 04 year: 2021 text: April 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Otolaryngology-head and neck surgery |
| PublicationTitleAlternate | Otolaryngol Head Neck Surg |
| PublicationYear | 2021 |
| SSID | ssj0006677 |
| Score | 2.4058316 |
| Snippet | Adjuvant management for laryngotracheal stenosis (LTS) may involve inhaled corticosteroids, but metered dose inhalers are designed for pulmonary drug delivery.... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 829 |
| SubjectTerms | Administration, Inhalation Administration, Oral Adrenal Cortex Hormones - administration & dosage Adrenal Cortex Hormones - chemistry Computer Simulation Humans Hydrodynamics Laryngostenosis - complications Laryngostenosis - drug therapy Models, Anatomic Particle Size Tracheal Stenosis - complications Tracheal Stenosis - drug therapy |
| Title | Orally Inhaled Drug Particle Transport in Computerized Models of Laryngotracheal Stenosis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33045904 https://www.proquest.com/docview/2450648294 |
| Volume | 164 |
| WOSCitedRecordID | wos000637858300018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3Ivga7JpLkycRdSi4OVBhPo00bWZhtLPdhPnrPWk79yQIPrQvbWg4PTn5cs7h-xC6iIRsaet5JAwkIyyOQxIqrgnjoZAcQqaildhE0O3Kfl_16oRbUbdVzmNiGaijzLgc-aXPHLWa9BW7Gn8Qpxrlqqu1hMYyalCAMq6lK-gv2MKFKJUXXZGVwJyCRZnyEpAN43DU8F0eTLh2v98AZrnRtDf_O8UttFFDTHxd-cQ2WorTHbTWqYvou-jtKdej0Qw_pO-wO0T4Np8Oca92IfzDdo6TFM81H5IveM_Jpo0KnFn8qPNZOswmuWODhk89TxzleFLsodf23cvNPakVFohhgIyIiGkUUCMsC43iPPKsspwCqIqpdUJWkrUMDT3jecYANDLMQDgMKLWKaWkC5e-jlTRL40OE4Y8LeAaB1wi4qBZStiwc36QWIuSmic7nRhuAB7uyhE7jbFoMFmZrooPK8oNxRbUxcNkWrjx29IfRx2jddw0nZVvNCWpYWL_xKVo1n5OkyM9K14B7t9f5BjSVwm0 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Orally+Inhaled+Drug+Particle+Transport+in+Computerized+Models+of+Laryngotracheal+Stenosis&rft.jtitle=Otolaryngology-head+and+neck+surgery&rft.au=Frank-Ito%2C+Dennis+Onyeka&rft.au=Cohen%2C+Seth+Morris&rft.date=2021-04-01&rft.eissn=1097-6817&rft.volume=164&rft.issue=4&rft.spage=829&rft_id=info:doi/10.1177%2F0194599820959674&rft_id=info%3Apmid%2F33045904&rft_id=info%3Apmid%2F33045904&rft.externalDocID=33045904 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1097-6817&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1097-6817&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1097-6817&client=summon |